암 발생예측 모형과 유전위험점수에 관한 고찰
Review on Genetic Risk Score and Cancer Prediction Models
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: In genome-wide association studies (GWASs), single-nucleotide polymorphisms (SNPs) that have been identified as cancer-associated loci are common, but they confer only small increases in risk. The question was whether combining multiple disease-related SNPs and the modest effects within Genetic Risk Score (GRS) may be useful in identifying subgroups that are at high risk of cancer. Methods: In this paper, we first reviewed articles that examined the predictability of GRS on cancer prediction models. Our data sources included a PubMed search of the literature published until February 2014. Secondly, we have calculated the GRS using the data example data with five SNPs related colorectal cancer (CRC) obtained from the Korean cancer prevention study II. Two approaches were used to calculate the GRS: a simple risk alleles count method (counted GRS) and a weighted method based on the genotype frequencies for each SNP and the effect sizes (allelic odds ratio or beta coefficient) from our study (weighted GRS). Results: Of 31 studies initially identified, 16 (135,110 participants) met the inclusion criteria. Among 16 articles, 7 studies were related to prostate cancer, 6 studies to breast cancer, and 3 studies to colon cancer and lung cancer. Fifteen studies except for one study concluded that in general, a genetic score may be helpful or useful in identifying the high risk group and particularly to determining the high risk individual among patients within a ‘‘gray zone’’ of cancer risk. The weighted GRS with age and sex (AUC=0.9333) had higher predictability on the CRC risk than the model with GRS alone (AUC=0.816). Conclusions: Although adding GRS improves prediction model performance, the clinical utility of these genetic risk models is limited. Nonetheless, the modelling suggests public health potential since it is possible to stratify the population into cancer risk categories, thereby informing targeted prevention and management.
Abstract
Objectives: In genome-wide association studies (GWASs), single-nucleotide polymorphisms (SNPs) that have been identified as cancer-associated loci are common, but they confer only small increases in risk. The question was whether combining multiple disease-related SNPs and the modest effects within Genetic Risk Score (GRS) may be useful in identifying subgroups that are at high risk of cancer. Methods: In this paper, we first reviewed articles that examined the predictability of GRS on cancer prediction models. Our data sources included a PubMed search of the literature published until February 2014. Secondly, we have calculated the GRS using the data example data with five SNPs related colorectal cancer (CRC) obtained from the Korean cancer prevention study II. Two approaches were used to calculate the GRS: a simple risk alleles count method (counted GRS) and a weighted method based on the genotype frequencies for each SNP and the effect sizes (allelic odds ratio or beta coefficient) from our study (weighted GRS). Results: Of 31 studies initially identified, 16 (135,110 participants) met the inclusion criteria. Among 16 articles, 7 studies were related to prostate cancer, 6 studies to breast cancer, and 3 studies to colon cancer and lung cancer. Fifteen studies except for one study concluded that in general, a genetic score may be helpful or useful in identifying the high risk group and particularly to determining the high risk individual among patients within a ‘‘gray zone’’ of cancer risk. The weighted GRS with age and sex (AUC=0.9333) had higher predictability on the CRC risk than the model with GRS alone (AUC=0.816). Conclusions: Although adding GRS improves prediction model performance, the clinical utility of these genetic risk models is limited. Nonetheless, the modelling suggests public health potential since it is possible to stratify the population into cancer risk categories, thereby informing targeted prevention and management.
참고문헌 (27)
- Chu YH, "MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma", PloS One, 9(2), pp.e89930~ (2014)
- Cerhan JR, "A pooled analysis of waist circumference and mortality in 650,000 adults", Mayo Clinic Proceedings, 89(3), pp.335~345 (2014)
- Morrison DS, "Behavioural and metabolic risk factors for mortality from colon and rectum cancer:analysis of data from the Asia-Pacific Cohort Studies Collaboration", Asian Pacific Journal Cancer of Prevention, 14(2), pp.1083~1087 (2013)
- Blakely T, "The association of active smoking with multiple cancers:national census-cancer registry cohorts with quantitative bias analysis", Cancer Causes & Control, 24(6), pp.1243~1255 (2013)
- Turnbull C, "Genome-wide association study identifies five new breast cancer susceptibility loci", Nature Genetics, 42(6), pp.504~507 (2010)
- Jiang H, "Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer riskassociated SNPs", The Prostate, 73(15), pp.1651~1659 (2013)
- Amos CI, "Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1", Nature Genetics, 40(5), pp.616~622 (2008)
- Purcell SM, "Common polygenic variation contributes to risk of schizophrenia and bipolar disorder", Nature, 460(7256), pp.748~752 (2009)
- 조재승, "Prediction of Colorectal Cancer Risk Using a Genetic Risk Score: The Korean Cancer Prevention Study-II (KCPS-II)", Genomics & Informatics, 10(3), pp.175~183 (2012), 한국유전체학회
- Yarnall JM, "Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer", Cancer Epidemiology, 37(3), pp.324~329 (2013)
- Li H, "Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model", BMC Medical Genetics, 10(13), pp.118~ (2012)
- Gail MH, "Projecting individualized probabilities of developing breast cancer for white females who are being examined annually", Journal of the National Cancer Institute, 81(24), pp.1879~1886 (1989)
- Gail MH, "Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk", Journal of the National Cancer Institute, 100(14), pp.1037~1041 (2008)
- Mealiffe ME, "Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information", Journal of the National Cancer Institute, 102(21), pp.1618~1627 (2010)
- McCarthy AM, "Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women", Breast Cancer and Research Treatment, 138(3), pp.889~898 (2013)
- Darabi H, "Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement", Breast Cancer Research, 14(1), pp.R25~ (2012)
- Rinella ES, "Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1", 2 mutation, 2013, pp.132(5), 523~536
- Ribeiro RJ, "Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction", PLoS One, 7(6), pp.e39236~ (2012)
- Lindström S, "Common genetic variants in prostate cancer risk prediction-results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)", Cancer Epidemiology, Biomarkers & Prevention, 21(3), pp.437~444 (2012)
- Aly M, "Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study", European Urology, 60(1), pp.21~28 (2011)
- Dunlop MG, "Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals", Gut, 62(6), pp.871~881 (2013)
- Pearce CL, "Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer", Cancer Epidemiology, Biomarkers & Prevention, 22(5), pp.880~890 (2013)
- Purrington KS, "Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer", Carcinogenesis, 35(5), pp.1012~1019 (2014)
- Tindall EA, "Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa", BMC Urology, 13, pp.74~ (2013)
- Butoescu V, "Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?", Prostate, 74(4), pp.365~371 (2014)
- He C, "Reproductive aging-associated common genetic variants and the risk of breast cancer", Breast Cancer Research, 14(2), pp.R54~ (2012)
- Zheng J, "Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer riskassociated SNPs", Prostate, 72(5), pp.577~583 (2012)